Cardiac Function and Microcirculation: Type 2 DIABetes and ECHOcardiographic Changes Over Time
DIABECHO
Systolic and Diastolic Left Ventricular Function in Patients With Type 2 DIABetes Mellitus: Changes Over Time and Comparison With Cardiac Microcirculation. An ECHOcardiographic Study
1 other identifier
observational
300
1 country
1
Brief Summary
The purpose of this study was to investigate the influence of micro- and macrovascular changes on the cardiac function in relation to left ventricular function and coronary arteries during one year in patients with type 2 diabetes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2016
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 16, 2016
CompletedFirst Submitted
Initial submission to the registry
October 30, 2016
CompletedFirst Posted
Study publicly available on registry
November 7, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 20, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 20, 2018
CompletedOctober 22, 2018
October 1, 2018
2.5 years
October 30, 2016
October 19, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in Global Longitudinal Strain (GLS) stratified by Coronary Artery Calcium Score (CAC) in patients with diabetes during one year of follow-up
To evaluate the changes in GLS stratified by CAC during one year of follow-up in patients with diabetes compared to non-diabetic subjects
baseline, 12 months
Secondary Outcomes (9)
Changes in GLS stratified by Coronary Flow Velocity Reserve (CFVR) in patients with diabetes during one year of follow-up
baseline, 12 months
Correlation between biomarkers and GLS stratified by CFVR
12 months
Correlation between biomarkers and GLS stratified by CAC
12 months
Changes in LV function stratified by CAC
baseline, 12 months
Changes in LV function stratified by CFVR
baseline, 12 months
- +4 more secondary outcomes
Other Outcomes (9)
Relationship between strain values and framerate
baseline, 12 months
Relationship between strain values and omitted myocardial segments
baseline, 12 months
Correlation between dysglycaemia and Left Ventricle Mass (LVM)
Baseline
- +6 more other outcomes
Study Arms (3)
T2
Patients with type 2 diabetes without myocardial infarction, heart failure and symptoms of cardiac disease at inclusion, were invited from the Outpatient Clinic of Endocrinology or The Eye Photo Clinic at Odense University Hospital (OUH) Svendborg. Diagnosis of diabetes was classified by trained endocrinologists according to international standards with relevant biochemistry. Historical data on urine- and blood samples as well as micro- and macrovascular diabetic complications have been registered consecutively in patients followed at the outpatient clinic in the regional Funen Diabetes Database (FDDB). Data on historical invasive procedures due to cardiac disease were registered in Western Denmark Heart Registry (WDHR).
T1
Patients with type 1 diabetes without myocardial infarction, heart failure and symptoms of cardiac disease at inclusion, were invited from the Outpatient Clinic of Endocrinology or The Eye Photo Clinic at OUH Svendborg. Diagnosis of diabetes was classified by trained endocrinologists according to international standards with relevant biochemistry. Historical data on urine- and blood samples as well as micro- and macrovascular diabetic complications have been registered consecutively in patients followed at the outpatient clinic in the regional FDDB. Data on historical invasive procedures due to cardiac disease were registered in WDHR.
Non-diabetic subjects
Non-diabetic subjects without myocardial infarction, heart failure and symptoms of cardiac disease at inclusion, were included from The Danish Cardiovascular Screening trial (DANCAVAS). A randomized controlled trial with the primary aim to evaluate the health benefits and costeffectiveness of using non-contrast full truncus computer tomography (CT) scans (to measure coronary artery calcification (CAC) and identify aortic/iliac aneurysms) and measurements of the ankle brachial blood pressure index (ABI) as part of a multifocal screening and intervention program for cardiovascular disease in men aged 65-74.
Eligibility Criteria
Patients with diabetes type 1+2 and non-diabetic subjects from the DANCAVAS trial (NCT00662480)
You may qualify if:
- Ability to give informed consent
- Estimated glomerular filtration rate (eGFR) \> 45 ml/min
- NYHA I + II
You may not qualify if:
- ° or 3° AV-block at baseline
- Long QT-syndrome at baseline
- Sinus node dysfunction with long sinus arrest at baseline
- Angina pectoris at baseline
- Ejection fraction (EF) \< 40% at baseline
- Atrial fibrillation at baseline
- Usage of dipyridamol at baseline
- Aortic stenosis and left ventricle hypertrophia at baseline
- Aortic insufficiency and left ventricle dilatation at baseline
- Medication for asthma within the last 4 years prior to baseline
- Medication for chronic obstructive pulmonary disease (COPD) at baseline
- Allergy to contrast agent at baseline
- Significant stenosis in left main (LM) / left anterior descending (LAD) artery at baseline
- Not feasible to measure or perform coronary flow velocity reserve (CFVR)
- Poor quality of echocardiographic images
- +6 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cardiovascular Research Unit, OUH Svendborg Hospital
Svendborg, 5700, Denmark
Biospecimen
Storage in biobank (-80° C): 5 x 2 ml (serum). 4 x 2 ml (ethylenediaminetetraacetic acid). 2 x 2 ml (sodium citrate) 1 x 2 ml (erythrocyte sedimentation rate)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Kenneth Egstrup, DMSci
Odense University Hospital (OUH) Svendborg Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, Ph.D-student
Study Record Dates
First Submitted
October 30, 2016
First Posted
November 7, 2016
Study Start
March 16, 2016
Primary Completion
September 20, 2018
Study Completion
September 20, 2018
Last Updated
October 22, 2018
Record last verified: 2018-10
Data Sharing
- IPD Sharing
- Will not share